Group 1 - The core viewpoint of the news is that Guangzhou Deep Medical Instrument Technology Co., Ltd. has completed a multi-million yuan Pre-A round financing, which will accelerate its clinical, registration, and market expansion efforts with the support of Wanfu Chuanggu [1][2] - The flagship product, FUNZAR, is an advanced surgical robot designed for microsurgery, featuring dual-arm 16 degrees of freedom, a 60x 4K ultra-high-definition 3D digital visual navigation system, and sub-micron level spatial positioning technology [1][2] - FUNZAR has successfully completed several clinical trials, including the world's first Alzheimer's deep cervical lymphatic end-to-end anastomosis surgery, demonstrating its feasibility and effectiveness in various microsurgical procedures [1][2] Group 2 - The chairman and founder of Deep Medical, Dr. Xia Jun, emphasized the strong demand for robotic assistance in microsurgery due to its complexity and the physical strain on surgeons [2] - Wanfu Chuanggu's investment leader, Mr. She Jin, highlighted significant breakthroughs in high-precision motion control and the adaptability of FUNZAR to microsurgical scenarios, which have been validated through preliminary clinical trials [2][3] - Strong Cloud Capital's Northern Region leader, Ms. Yan Guopei, noted the impressive product detail control, team efficiency, and comprehensive patent layout of Deep Medical, positioning it as a leader in the promising field of surgical robotics [3]